 |
CW Technologies and Technology Transfer:
Brainsgate Ltd.
BrainsGate, an Israel-based company, was in need of collaborators for clinical trials of an implantable medical device for use in drug delivery to the central nervous system. After having conducted preliminary studies in animals, BrainsGate was ready to pursue human trials for the device, a general and widely adaptable platform for drug delivery to the brain. CWT helped partner BrainsGate with Wisconsin physician researchers interested in pursuing trials and facilitated negotiation over details of the collaboration and research protocol.
More information on BrainsGate:
Cognifit
Cognifit uses cutting edge research in learning and memory to create "mind fitness solutions"--computer programs that exercise basic mental processes and keep the brain functioning optimally. A key application of Cognifit's technology is Mindfit™, a solution designed to stimulate short term memory, attention, visual perception and other key functions. Just as physical exercise can slow the physical symptoms of aging, mental exercise can ensure that the mind stays fit in later life. Mindfit™ presents a unique new way to improve quality of life for older adults and help slow the progression neurodegenerative diseases such as Alzheimers and dementia. CWT is currently exploring options to help bring this technology to Wisconsin seniors.
More information on Cognifit:
Gene Vector Technologies Ltd.
Gene Vector Technologies (GVT) core technology is a new platform for gene therapy. Many current approaches rely on the use of active viruses to deliver therapeutic genetic material. However, as with live-virus vaccines, this therapeutic use of viruses risks serious side-effects in a small number of the patients treated. Instead of using 'live' viruses to deliver genetic materials, GVT's technology represents a change of paradigm. Instead of using a live virus or potentially toxic chemical treatment, GVT uses only a small set of viral proteins to assemble its delivery vector. The result is a lab-manufactured pseudo-virus made from controlled compounds that can deliver genes into the body while avoiding hazards of an active virus. CWT is currently investigating collaborations on GVT technology.